Nippon Life Global Investors Americas’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,381
Closed -$1.61M 150
2021
Q4
$1.61M Hold
20,381
0.08% 139
2021
Q3
$1.61M Sell
20,381
-157,184
-89% -$12.6M 0.08% 134
2021
Q2
$14M Sell
177,565
-51,529
-22% -$3.95M 0.7% 41
2021
Q1
$17.3M Buy
229,094
+13,014
+6% +$954K 0.94% 29
2020
Q4
$14.2M Buy
216,080
+126,472
+141% +$7.39M 0.85% 35
2020
Q3
$4.84M Sell
89,608
-15,936
-15% -$875K 0.32% 77
2020
Q2
$5.07M Buy
105,544
+94,400
+847% +$4.17M 0.36% 70
2020
Q1
$380K Sell
11,144
-91,385
-89% -$5.02M 0.03% 127
2019
Q4
$6.42M Buy
102,529
+71,149
+227% +$4.02M 0.44% 69
2019
Q3
$1.57M Buy
+31,380
New +$1.48M 0.12% 128

Other funds holding ENOV

Nippon Life Global Investors Americas's ENOV Position: Q1 2022 in Review

Nippon Life Global Investors Americas sold out of Enovis (ENOV) in Q1 2022, closing a stake of 20,381 shares — an estimated $1.61M sold.

Nippon Life Global Investors Americas first reported a position in ENOV in Q3 2019 and held it in 10 quarters. The position peaked at $17.3M in Q1 2021. 298 funds tracked by Wall St. Rank hold ENOV as of Q1 2022.

  • Nippon Life Global Investors Americas reported no remaining Enovis position as of Q1 2022 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 20,381 Enovis shares in Q1 2022, an estimated $1.61M.
  • Nippon Life Global Investors Americas first reported a position in Enovis in Q3 2019 and held it in 10 quarters.
  • Nippon Life Global Investors Americas's Enovis position peaked at $17.3M in Q1 2021.
  • 298 funds tracked by Wall St. Rank held Enovis as of Q1 2022.

Based on Nippon Life Global Investors Americas's 13F filing for Q1 2022, filed 11 May 2022.